Source: International Congress 2018 – Eosinophils in airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Prudente (Botucatu, Brazil), C. Mesquita (Botucatu, Brazil), R. Ferrari (Botucatu, Brazil), E. Franco (Botucatu, Brazil), S. Tanni (Botucatu, Brazil). Peripheral eosinophils and mortality in COPD patients over nine years. 5383

Member's Comments

No comment yet.

Related content which might interest you: Blood eosinophils and exacerbation rate in COPD patients over three years Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 The relationship between blood neutrophils, blood eosinophils and exacerbations of COPD – Results from the TIE-study Source: International Congress 2016 – Systemic biomarkers Year: 2016 The rate of re-exacerbation in patients hospitalized with eosinophil and non-eosinophilic COPD relapses Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020 Blood eosinophil count and exacerbation risk in patients with COPD Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017 Year: 2017 Analysis of peripheral blood lymphocytes in asthma and chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2010 - Lung cell biology and immunology Year: 2010 Peripheral neutrophil stiffness is increased in COPD severe exacerbations Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012 Peripheral neutrophil stiffness in severe COPD exacerbations Source: Annual Congress 2011 - COPD: human studies Year: 2011 Stability of eosinophils in blood in patients with chronic obstructive pulmonary diseasee (COPD) and one hospital admission Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020 Association between blood eosinophil count and risk of exacerbations in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Activated neutrophils are increased in bronchial biopsies from patients with severe COPD Source: Eur Respir J 2004; 24: Suppl. 48, 718s Year: 2004 Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Stability of blood eosinophils over time in patients with asthma Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD Source: Eur Respir J, 51 (5) 1800120; 10.1183/13993003.00120-2018 Year: 2018 Can blood eosinophils predict sputum eosinophils in stable COPD? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Treatment of moderate-severe asthma with omalizumab is associated with a decrease in peripheral blood eosinophils Source: Eur Respir J 2007; 30: Suppl. 51, 353s Year: 2007 Blood eosinophils and outcomes in COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Elevated blood eosinophils on admission for a severe exacerbation of COPD is not a predictor for survival Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Clinical factors associated with baseline blood eosinophils among patients with asthma or COPD: NOVELTY study Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020